Recurrent Giant Cell Tumour of Distal End Radius: Treatment and Outcomes After Further Surgeries

Introduction: Distal end radius is the second most common location for giant cell tumours (GCTs) followed by the knee. Like at any other location, they are treated with extended curettage or resection but reportedly have an increased propensity for recurrence. This study aims to treat the recurrent distal end radius GCTs and their outcome after further surgeries. Patients and methods: This study was conducted retrospectively from 2009 to 2021 and included 32 patients with recurrent distal end radius GCTs with a mean age of 29.53 years (range: 18-45 years). Twenty-five recurrences occurred after curettage and seven after resection. Twelve lesions were treated with further extended curettage. Nineteen recurrent lesions were treated with resection and arthrodesis. One out of two soft tissue recurrences was treated with en bloc resection. The mean follow-up period was 45.25 months (range: 24-120). Results: The patients with joint preservations treated with further curettage and those where resection of soft tissue recurrences was done with salvage of joint had better functional outcomes with a mean Musculoskeletal Tumor Society (MSTS) score of 26.53 (Range: 22-30). The cases with arthrodesis had an average score of 23.75 (Range: 20-26). The overall average MSTS score was 24.89. Conclusions: We conclude that local recurrence contained within the bone can be re-curetted. The isolated soft tissue recurrences can be re-excised. The bony lesions with extensive soft tissue extension should be treated with resection and reconstruction. The re-recurrence rate after further adequate treatment does not increase much.

[1]  Qing-cheng Yang,et al.  Factors Affecting the Recurrence of Giant Cell Tumor of Bone After Surgery: A Clinicopathological Study of 80 Cases from a Single Center , 2015, Cellular Physiology and Biochemistry.

[2]  F. Sim,et al.  Recurrent Giant Cell Tumor of Long Bones: Analysis of Surgical Management , 2011, Clinical orthopaedics and related research.

[3]  F. Sim,et al.  Giant Cell Tumor of Bone: Risk Factors for Recurrence , 2011, Clinical orthopaedics and related research.

[4]  M. Szendrői,et al.  Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy. , 2008, The Journal of bone and joint surgery. American volume.

[5]  M. Balke,et al.  Giant cell tumor of bone: treatment and outcome of 214 cases , 2008, Journal of Cancer Research and Clinical Oncology.

[6]  A. Rydholm,et al.  Treatment of local recurrences of giant cell tumour in long bones after curettage and cementing. A Scandinavian Sarcoma Group study. , 2006, The Journal of bone and joint surgery. British volume.

[7]  R. Grimer,et al.  Does Curettage without Adjuvant Therapy Provide Low Recurrence Rates in Giant-Cell Tumors of Bone? , 2005, Clinical orthopaedics and related research.

[8]  J. Harrelson,et al.  Giant-Cell Tumor of the Appendicular Skeleton , 2002, Clinical orthopaedics and related research.

[9]  A. Davis,et al.  Giant Cell Tumor of Long Bone: A Canadian Sarcoma Group Study , 2002, Clinical orthopaedics and related research.

[10]  T. Yamashita,et al.  Complications associated with bone cementing for the treatment of giant cell tumors of bone , 2002, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[11]  L. Sobin,et al.  World Health Organization classification of tumors , 2000, Cancer.

[12]  V. Jansson,et al.  Phenol as an adjuvant for local control in the treatment of giant cell tumour of the bone. , 1999, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[13]  B. Hamlin,et al.  Thermal effects of acrylic cementation at bone tumour sites. , 1997, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[14]  R. O'Donnell,et al.  Recurrence of giant-cell tumors of the long bones after curettage and packing with cement. , 1994, The Journal of bone and joint surgery. American volume.

[15]  L. Everson,et al.  Staging of musculoskeletal tumors. , 1994, Radiologic clinics of North America.

[16]  W. Enneking.  A system of staging musculoskeletal neoplasms. , 1986, Clinical orthopaedics and related research.

[17]  A. Rydholm,et al.  Early radiologic detection of local recurrence after curettage and acrylic cementation of giant cell tumours. , 1986, European journal of radiology.

[18]  A. Rydholm,et al.  Bone cement, thermal injury and the radiolucent zone. , 1984, Acta orthopaedica Scandinavica.

[19]  M. Malawer.  Surgical management of aggressive and malignant tumors of the proximal fibula. , 1984, Clinical orthopaedics and related research.

[20]  B. Gunterberg,et al.  Favourable results of acrylic cementation for giant cell tumors. , 1984, Acta orthopaedica Scandinavica.

[21]  J. Struthers,et al.  Giant-Cell Tumour of Bone , 1939, Edinburgh medical journal.

[22]  P. Chu,et al.  Tumors of soft tissue and bone , 2014 .

[23]  W. Winkelmann,et al.  Treatment options for recurrent giant cell tumors of bone , 2008, Journal of Cancer Research and Clinical Oncology.

[24]  W. Enneking,et al.  A System for the Surgical Staging of Musculoskeletal Sarcoma , 1980, Clinical orthopaedics and related research.

[25]  J. W. Wang,et al.  Treatment of giant cell tumor of bone: a comparison of local curettage and wide resection. , 1998, Changgeng yi xue za zhi.

[26]  P. K. Jensen,et al.  Local recurrences in giant cell tumour of bone , 1996, International Orthopaedics.

[27]  N. Baldini,et al.  Giant-cell tumor of bone. , 1987, The Journal of bone and joint surgery. American volume.